Colonoscopy Clinical Trial
Official title:
Effect of Intervention for Improving Colonoscopy Quality is Associated With the Personal Characteristics of the Endoscopist
Verified date | September 2020 |
Source | Seoul St. Mary's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to investigate whether the personal characteristics of the endoscopist is
associated with effect of interventions for colonoscopy quality improvement.
This is a prospective, 9-month, multicenter, single-blind study. Baseline quality indicators
including adenoma detection rate, polyp detection rate, withdrawal time and adenomas per
colonoscopy of each endoscopist were measured in the health promotion centers of academic
hospitals for 3 months. Follow-up measurements of quality indicators were repeated every 3
months after each interventions (personal notification of quality indicators, open
notification of quality indicators, and colonoscopy quality education by a GI faculty. At the
end of the study, personal characteristics of each endoscopist was evaluated using fear of
negative evaluation scale, cognitive flexibility inventory, and almost perfect scale.
Status | Completed |
Enrollment | 15 |
Est. completion date | February 12, 2020 |
Est. primary completion date | December 12, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Highly experienced board-certified gastroenterologists performed colonoscopies in health screening endoscopy centers. - Endoscopists who sign the consent - Patients for quality indicators of endoscopists - routinely perform outpatient screening, surveillance and diagnostic colonoscopy (first-time screening colonoscopies performed and had no previous colonoscopy within 3 years). Exclusion Criteria: - endoscopists who refuse to sign the consent - Patients for quality indicators of endoscopists - Known hereditary polyposis syndrome, Inflammatory bowel disease, those with surgically altered anatomy, undergone previous colonoscopy within 3 years |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Division of Gastroenterology; Seoul St. Mary's hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
Seoul St. Mary's Hospital | Saint Vincent's Hospital, Korea, Uijeongbu St. Mary Hospital |
Korea, Republic of,
Coe SG, Crook JE, Diehl NN, Wallace MB. An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol. 2013 Feb;108(2):219-26; quiz 227. doi: 10.1038/ajg.2012.417. Epub 2013 Jan 8. — View Citation
Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E; COLONPREV Study Investigators. Endoscopist characteristics that influence the quality of colonoscopy. Endoscopy. 2016 Mar;48(3):241-7. doi: 10.1055/s-0042-100185. Epub 2016 Feb 4. — View Citation
Shaukat A, Oancea C, Bond JH, Church TR, Allen JI. Variation in detection of adenomas and polyps by colonoscopy and change over time with a performance improvement program. Clin Gastroenterol Hepatol. 2009 Dec;7(12):1335-40. doi: 10.1016/j.cgh.2009.07.027. Epub 2009 Aug 7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measurement of overall adenoma detection rate | Primary outcome measures include overall adenoma detection rate. | 9 months | |
Primary | Measurement of adenoma detection rate after personal notification | Primary outcome measures include adenoma detection rate after personal notification | 3 months after personal notification | |
Primary | Measurement of adenoma detection rate after open notification | Primary outcome measures include adenoma detection rate after open notification | 3 months after open notification | |
Primary | Measurement of adenoma detection rate after education | Primary outcome measures include adenoma detection rate after education | 3 months after education | |
Secondary | Measurement of overall polyp detection rate | Secondary outcome measures include overall polyp detection rate. | 9 months | |
Secondary | Measurement of overall withdrawal time | Secondary outcome measures include overall withdrawal time. | 9 months | |
Secondary | Measurement of overall adenomas per colonoscopy | Secondary outcome measures include overall adenomas per colonoscopy. | 9 months | |
Secondary | Measurement of polyp detection rate after personal notification | Primary outcome measures include polyp detection rate after personal notification | 3 months after personal notification | |
Secondary | Measurement of polyp detection rate after open notification | Primary outcome measures include polyp detection rate after open notification | 3 months after open notification | |
Secondary | Measurement of polyp detection rate after education | Primary outcome measures include polyp detection rate after education | 3 months after education | |
Secondary | Measurement of withdrawal time after personal notification | Primary outcome measures include withdrawal time after personal notification | 3 months after personal notification | |
Secondary | Measurement of withdrawal time after open notification | Primary outcome measures include withdrawal time after open notification | 3 months after open notification | |
Secondary | Measurement of withdrawal time after education | Primary outcome measures include withdrawal time after education | 3 months after education | |
Secondary | Measurement of adenomas per colonoscopy after personal notification | Primary outcome measures include adenomas per colonoscopy after personal notification. | 3 months after personal notification | |
Secondary | Measurement of adenomas per colonoscopy after open notification | Primary outcome measures include adenomas per colonoscopy after open notification | 3 months after open notification | |
Secondary | Measurement of adenomas per colonoscopy after education | Primary outcome measures include adenoma detection rate after education | 3 months after education |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04101097 -
Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
|
||
Completed |
NCT03247595 -
Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy
|
N/A | |
Completed |
NCT04214301 -
An Open-Label Preference Evaluation of BLI800
|
Phase 4 | |
Withdrawn |
NCT05754255 -
Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center
|
N/A | |
Recruiting |
NCT02484105 -
Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction
|
Phase 4 | |
Active, not recruiting |
NCT02264249 -
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
|
N/A | |
Completed |
NCT01964417 -
The Comparative Study Between Bowel Preparation Method
|
Phase 3 | |
Terminated |
NCT01978509 -
The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies
|
N/A | |
Recruiting |
NCT01685970 -
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
|
Phase 3 | |
Completed |
NCT01518790 -
Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children
|
N/A | |
Recruiting |
NCT00748293 -
Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet
|
N/A | |
Completed |
NCT00779649 -
MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial
|
Phase 4 | |
Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
Completed |
NCT00380497 -
Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children
|
Phase 4 | |
Recruiting |
NCT00160823 -
Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
|
Phase 3 | |
Completed |
NCT00390598 -
PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
|
Phase 2/Phase 3 | |
Completed |
NCT00314418 -
Patient Position and Impact on Colonoscopy Time
|
N/A | |
Completed |
NCT00209573 -
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
|
Phase 3 | |
Completed |
NCT00427089 -
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
|
Phase 3 | |
Completed |
NCT05823350 -
The Effect of Abdominal Massage on Pain and Distention After Colonoscopy
|
N/A |